123 related articles for article (PubMed ID: 3150319)
1. Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women.
Matta WH; Shaw RW; Hesp R; Evans R
Clin Endocrinol (Oxf); 1988 Jul; 29(1):45-51. PubMed ID: 3150319
[TBL] [Abstract][Full Text] [Related]
2. Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol.
Dawood MY; Lewis V; Ramos J
Fertil Steril; 1989 Jul; 52(1):21-6. PubMed ID: 2501109
[TBL] [Abstract][Full Text] [Related]
3. Hormone treatment related bone mineral content changes in Japanese women with endometriosis.
Fukushima M; Shindo M; Sato K
Asia Oceania J Obstet Gynaecol; 1993 Sep; 19(3):299-307. PubMed ID: 8250765
[TBL] [Abstract][Full Text] [Related]
4. Changes in bone mineral content following hormone treatment for endometriosis.
Fukushima M
Int J Gynaecol Obstet; 1995 Sep; 50 Suppl 1():S17-22. PubMed ID: 8529770
[TBL] [Abstract][Full Text] [Related]
5. Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma.
Ito M; Sakoda Y; Okamura H
Endocrinol Jpn; 1990 Dec; 37(6):907-13. PubMed ID: 1966283
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
Stevenson JC; Lees B; Gardner R; Shaw RW
Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects on bone mineral density and bone metabolism of 6 months' treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate.
Makita K; Ishitani K; Ohta H; Horiguchi F; Nozawa S
J Bone Miner Metab; 2005; 23(5):389-94. PubMed ID: 16133689
[TBL] [Abstract][Full Text] [Related]
8. Low-dose GnRH agonist therapy for the management of endometriosis.
Uemura T; Shirasu K; Katagiri N; Asukai K; Suzuki T; Suzuki N; Osada H; Hiroshi M
J Obstet Gynaecol Res; 1999 Oct; 25(5):295-301. PubMed ID: 10533322
[TBL] [Abstract][Full Text] [Related]
9. Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.
Matta WH; Shaw RW; Hesp R; Katz D
Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1523-4. PubMed ID: 3111619
[No Abstract] [Full Text] [Related]
10. Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol.
Tummon IS; Ali A; Pepping ME; Radwanska E; Binor Z; Dmowski WP
Fertil Steril; 1988 May; 49(5):792-6. PubMed ID: 3129312
[TBL] [Abstract][Full Text] [Related]
11. Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma.
Waibel-Treber S; Minne HW; Scharla SH; Bremen T; Ziegler R; Leyendecker G
Hum Reprod; 1989 May; 4(4):384-8. PubMed ID: 2526152
[TBL] [Abstract][Full Text] [Related]
12. [Bone mineral content in premenopausal women treated with gonadotropin-releasing hormone analogue].
Masahashi T; Negoro Y; Asai M; Suzuki M; Noguchi M; Nakanishi M; Tomita A
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):577-80. PubMed ID: 1619317
[TBL] [Abstract][Full Text] [Related]
13. Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.
Shaw RW
Prog Clin Biol Res; 1990; 323():383-92. PubMed ID: 2137621
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of gonadotropin-releasing hormone agonist (buserelin) in the treatment of endometriosis.
Rönnberg L; Koskimies A; Laatikainen T; Ranta T; Saastamoinen J
Acta Obstet Gynecol Scand; 1989; 68(1):49-53. PubMed ID: 2508418
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral content of the femoral neck and shaft: relation between cortical and trabecular bone.
Bohr H; Schaadt O
Calcif Tissue Int; 1985 Jul; 37(4):340-4. PubMed ID: 3930028
[TBL] [Abstract][Full Text] [Related]
16. Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis.
Uemura T; Mohri J; Osada H; Suzuki N; Katagiri N; Minaguchi H
Fertil Steril; 1994 Aug; 62(2):246-50. PubMed ID: 8034067
[TBL] [Abstract][Full Text] [Related]
17. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
Dodin S; Lemay A; Maheux R; Dumont M; Turcot-Lemay L
Obstet Gynecol; 1991 Mar; 77(3):410-5. PubMed ID: 1825135
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional quantitative CT of the proximal femur: relationship to vertebral trabecular bone density in postmenopausal women.
Bhasin S; Sartoris DJ; Fellingham L; Zlatkin MB; Andre M; Resnick D
Radiology; 1988 Apr; 167(1):145-9. PubMed ID: 3347716
[TBL] [Abstract][Full Text] [Related]
19. Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause.
Riggs BL; Wahner HW; Melton LJ; Richelson LS; Judd HL; Offord KP
J Clin Invest; 1986 May; 77(5):1487-91. PubMed ID: 3700651
[TBL] [Abstract][Full Text] [Related]
20. [Changes in bone mass with age. Transversal study on a female population using photon densitometry].
Palummeri E; Girasole G; Davoli L; Bergonzani M; Pioli G; Meola P; Butturini L; Barbagallo M; Ciotti G; Pedrazzoni M
Minerva Med; 1987 Jun; 78(12):809-14. PubMed ID: 3601128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
